| 0 (0%) | 09-27 14:45 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 30.64 | 1-year : | 33 |
| Resists | First : | 26.23 | Second : | 28.26 |
| Pivot price | 25.19  |
|||
| Supports | First : | 22.95 | Second : | 19.1 |
| MAs | MA(5) : | 25.7 |
MA(20) : | 25.64 |
| MA(100) : | 28.93 |
MA(250) : | 36.63 |
|
| MACD | MACD : | -1.2 |
Signal : | -1.5 |
| %K %D | K(14,3) : | 61.9 |
D(3) : | 59.2 |
| RSI | RSI(14): 45.7 |
|||
| 52-week | High : | 81.73 | Low : | 18.92 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ VKTX ] has closed below upper band by 40.1%. Bollinger Bands are 51.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 25.67 - 25.8 | 25.8 - 25.91 |
| Low: | 24.58 - 24.73 | 24.73 - 24.85 |
| Close: | 25.35 - 25.58 | 25.58 - 25.77 |
Fri, 26 Sep 2025
Viking Therapeutics: A Huge Reward Or A Total Loss (NASDAQ:VKTX) - Seeking Alpha
Thu, 25 Sep 2025
Viking Therapeutics (NASDAQ:VKTX) Shares Down 5.8% - Here's Why - MarketBeat
Thu, 25 Sep 2025
Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors - Yahoo Finance
Thu, 25 Sep 2025
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet - Yahoo Finance
Wed, 24 Sep 2025
Are Safety Concerns Around VK2735 Shaping Investor Perceptions of Viking Therapeutics (VKTX)? - simplywall.st
Tue, 23 Sep 2025
Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 112 (M) |
| Shares Float | 220 (M) |
| Held by Insiders | 2.1 (%) |
| Held by Institutions | 68.3 (%) |
| Shares Short | 26,680 (K) |
| Shares Short P.Month | 28,700 (K) |
| EPS | -1.54 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.07 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -15 % |
| Return on Equity (ttm) | -20 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -153 (M) |
| Levered Free Cash Flow | -102 (M) |
| PE Ratio | -16.61 |
| PEG Ratio | 0 |
| Price to Book value | 3.61 |
| Price to Sales | 0 |
| Price to Cash Flow | -18.85 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|